HOME >> BIOLOGY >> NEWS
Project BioShield: Consistent financing, markets, indemnity for biodefense vaccine developers needed

aping of Project BioShield that would affect its ability to attract biotechnology companies to participate.

Need for a Long-term, Sizeable Government Commitment

Dr. Ryan said that her primary concern revolved around whether the BioShield initiative and corresponding efforts at the DoD represent a long-term government commitment of sufficient size to make the venture worthwhile for companies. She noted that the market created by BioShield must be large enough to convince biotechnology companies that they have a partner who understands the high cost, complexity, and significant risk of developing therapeutics and bringing them to market. "Biotechnology companies need to see a federal program of sufficient size to convince them that their efforts can be funded through to product commercialization and that the risk that they ensure and the success they achieve will be fairly compensated," she said.

She further voiced the need for a long-term commitment of such funding, to ensure adequate resources over the many years it can take to develop biomedical countermeasures against difficult disease agents. "I believe the government understands that meeting the biological weapons threat is of similar importance to the nuclear threat in many respects. The Strategic Defense Initiative, which celebrated its 20th anniversary last month, launched a missile defense program whose funding has not dropped below $3 billion dollars annually over two decades. That kind of long-range commitment will convince companies that the government is a serious partner in this undertaking," Dr. Ryan said. She commented that while work on vaccines against anthrax and plague was proceeding rapidly, other less well understood agents, such as viral pathogens and hemorrhagic fevers like Ebola, could pose significantly more difficult problems for vaccine developers, making long-term research and development funding crucial.

Consistent, Coordinated and Transpar
'"/>

Contact: Joan Kureczka
JKureczka@aol.com
415-821-2413
Kureczka/Martin Associates
4-Apr-2003


Page: 1 2 3 4

Related biology news :

1. Virginia Tech researchers to release findings on Smith River Project
2. Tools from the Human Genome Project reveal a versatile microbe
3. Project to make smallpox inoculations safe by leashing current vaccine virus
4. Francis Collins and Ari Patrinos receive Energy Secretarys Gold Award for Human Genome Project
5. AAAS Science Project/Unisys prize encourages student-led scientific inquiry on flight to soar
6. UT Southwestern named one of 10 NIH centers for Human Proteome Project
7. NSF awards $4.3 million to Rutgers for Maize Genome Sequencing Project
8. Moffitt Cancer Center receives DoD funds to establish National Functional Genomics Project
9. Darwins letters being sent to Galapagos Islands as part of Darwin Correspondence Project
10. Ames chemist wins national award for contributions to Human Genome Project
11. Virginia Tech researchers join NSF Arabidopsis 2010 Project; may help produce plants that defend themselves without pesticides

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/4/2020)... ... March 04, 2020 , ... RoosterBio Inc., a ... bioprocess systems, announces today a significant milestone in the regenerative medicine field with ... patient has been treated by RoosterBio’s pharmaceutical customer with an Investigational New Drug ...
(Date:3/3/2020)... ... March 03, 2020 , ... Board-certified oral and maxillofacial surgeon, Dr. Michael Noffze ... of training and experience, Dr. Noffze can successfully extract problem and impacted wisdom teeth ... possible is beneficial to the oral and overall health of most patients as these ...
(Date:3/2/2020)... ... 2020 , ... Philadelphia IP law firm Panitch Schwarze Belisario & Nadel LLP ... as a Partner, and Stephany G. Small, Ph.D., has joined the firm as a ... a partner in the firm’s biotechnology and life science practice group. He has significant ...
Breaking Biology News(10 mins):
(Date:2/3/2020)... ... February 03, 2020 , ... Global ... announce that OmniType, the 11-locus, single tube multiplex successor to Holotype HLA is ... product featuring locus-multiplexing and short library preparation, for HLA genotyping from sample to ...
(Date:1/28/2020)... ... January 28, 2020 , ... Genedata, the ... release of Genedata Expressionist ® 13.5 at the 2020 WCBP Symposium. ... (MAM) for characterizing and monitoring the quality of biopharmaceuticals throughout their development ...
(Date:1/27/2020)... (PRWEB) , ... January 27, 2020 , ... ... advances in neuroscience and cloud and mobile computing, today announced the availability of ... across an organization to use the latest neuroscience of leadership and change research ...
(Date:1/24/2020)... PLAINS, N.J. (PRWEB) , ... January 24, 2020 , ... ... at The Plastic Surgery Center in New Jersey epitomize the notion that plastic surgery ... surgery is typically characterized in popular media. , Over the last 20 years NJ ...
Breaking Biology Technology:
Cached News: